MADELINE WINGARD: Open Payments
NPI 1841801453 · COLLEYVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 57 payments from 21 companies in 2025. Trend: 2023 $945 · 2024 $2,199 · 2025 $1,171
Food & beverage: $1,106Education: $65
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $155 |
| AstraZeneca Pharmaceuticals LP | 6 | $139 |
| PFIZER INC. | 6 | $125 |
| Medtronic, Inc. | 2 | $119 |
| Exact Sciences Corporation | 4 | $79 |
| Lilly USA, LLC | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $52 |
| Azurity Pharmaceuticals, Inc. | 3 | $49 |
| Tris Pharma Inc | 2 | $48 |
Products named: VENASEAL, FARXIGA, Ozempic, PREVNAR 20, Cologuard Collection Kit, CAPLYTA, REXULTI, Dyanavel XR.
Industry payments across TX — which companies pay providers there.
